Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy
- Status
- COMPLETED
- Phase
- PHASE4
An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy
- Status
- UNKNOWN
- Phase
- PHASE2
Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion
- Status
- UNKNOWN
- Phase
- PHASE2
TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors
- Status
- RECRUITING
- Phase
- PHASE3